Regulatory Submissions AI Stack

Why Regulatory Submissions AI Is About Speed and Consistency, Not Replacement

Regulatory submissions are where AI adoption is most cautious — and rightfully so. The tools used to prepare and review submission documents don't typically generate regulatory data themselves, but they influence the quality, consistency, and completeness of what goes to the FDA and EMA. The compliance boundary is nuanced: AI that helps format an eCTD module is in a different category than AI that generates the clinical data within it.

The submission process involves thousands of documents organized across CTD modules, with cross-references that must be internally consistent. A single Module 2 summary might reference data from dozens of Module 5 study reports. Manual management of this complexity is where errors creep in and timelines slip.

The Submissions Problem: What AI Is Actually Solving

Document drafting acceleration. AI writing assistants can accelerate the drafting of Module 2 summaries, clinical overviews, nonclinical overviews, and clinical study reports. These tools produce first drafts that qualified medical writers refine and validate rather than building from scratch.

Cross-reference integrity. AI tools can scan submission documents for internal consistency — ensuring that data cited in summaries matches source study reports, that table numbers are referenced correctly, and that terminology is used consistently across modules.

Regulatory intelligence. AI tools that monitor regulatory agency publications, track guidance updates, and analyze approval precedents give regulatory affairs teams a significant information advantage. These tools surface relevant FDA complete response letters, EMA assessment reports, and advisory committee transcripts for comparable products.

eCTD assembly and validation. AI-powered eCTD tools automate the mechanical assembly of submission packages — document formatting, hyperlink generation, PDF bookmarking, granularity checks, and technical validation against regional requirements.

The Recommended Regulatory Submissions AI Stack

Layer 1: Regulatory Intelligence — Cortellis Regulatory Intelligence (Clarivate)

Cortellis Regulatory Intelligence provides AI-powered regulatory tracking across 200+ countries. The platform monitors regulatory agency actions, guidance publications, and approval decisions, delivering alerts when changes affect your development program.

For submission strategy, Cortellis's analytics can surface precedent — how similar products were reviewed, what questions advisory committees raised, and what deficiencies appeared in complete response letters for comparable applications. This intelligence directly informs your submission strategy and pre-submission meeting preparation.

Alternative: IQVIA's RegulatoryOne platform provides regulatory intelligence integrated with IQVIA's broader clinical development analytics. For teams focused primarily on FDA, the FDA's own FAERS and Drugs@FDA databases are free but require manual analysis.

Layer 2: Document Drafting and Review — Automated Medical Writing Platforms

Several AI-powered platforms now support regulatory document drafting. These tools generate structured first drafts of CSRs, Module 2 summaries, and investigator brochures from study data and protocol specifications. The medical writer reviews, refines, and validates the output rather than writing from scratch.

Key platforms include Genpact's regulatory writing suite, which uses GenAI to produce draft regulatory documents from structured clinical data, and emerging tools from established regulatory publishing vendors like Lorenz Life Sciences.

The critical principle: AI drafts the container, humans validate the science. Every AI-generated claim, data point, and conclusion requires human verification against source data.

Alternative: For teams using general-purpose AI (Claude, GPT) for initial drafting, establish a clear SOP for validation and version control. The output quality depends heavily on prompt engineering and the specificity of input data provided.

Layer 3: eCTD Publishing and Validation — EXTEDO (Amplexor)

EXTEDO provides end-to-end eCTD lifecycle management, from document authoring through electronic submission to global regulatory agencies. The platform automates PDF conversion, bookmark generation, hyperlink management, and technical validation against ICH and regional eCTD specifications.

For AI-assisted features, EXTEDO's platform can identify incomplete sections, flag formatting inconsistencies, and validate cross-references across the submission package before publishing.

Alternative: Veeva Vault RIM (Regulatory Information Management) provides regulatory submissions management within the Veeva ecosystem. For teams using Documentum or SharePoint-based publishing workflows, GlobalSubmit and Ennov offer eCTD publishing tools with varying levels of AI assistance.

Implementation Guide

Step 1: Start with regulatory intelligence. Deploy Cortellis or equivalent to inform your submission strategy. The intelligence feeds every downstream decision — timing, content, and engagement strategy.

Step 2: Pilot AI-assisted drafting on low-risk documents. Start with investigator brochure updates or annual report sections — documents where AI acceleration is valuable but the regulatory risk of errors is manageable.

Step 3: Scale to CSR and Module 2 drafting. Once your team is comfortable with AI-assisted review workflows, expand to clinical study reports and Module 2 summaries.

Step 4: Automate eCTD assembly. For organizations with multiple submissions annually, automated eCTD publishing eliminates the mechanical assembly bottleneck.

ROI and Evidence

• AI-assisted regulatory document drafting reduces first-draft time by 60–80%, shifting medical writer effort from creation to review and validation
• Automated cross-reference checking catches 15–25% of internal inconsistencies that manual review misses
• eCTD automation reduces publishing cycle time from weeks to days for experienced organizations
• Regulatory intelligence platforms reduce competitive analysis time by 70% compared to manual agency database searching
• Faster submission preparation can compress regulatory review timelines by 2–4 months per submission

Compliance callout

The credibility assessment framework applies when AI tools generate data inside a submission — not when they help prepare the submission document itself. However, document the AI tools used in submission preparation as part of your quality management system. If AI-generated content influences the interpretation or presentation of clinical data, that's within scope. See our AI Compliance section for guidance.

---

This guide is part of the ClinStacks AI Stack series. View all stacks → · Previous: Medical Imaging → · Next: Clinical Documentation →